IL15 and neoplasm: We incorporated genes encoding secretable immune modulators IL-12, IL-15, IL-15RA, and a PD-L1 blocking peptide into VG161 to promote durable anti-tumor immunity by enhancing TH1 polarization and the inflammatory response within the tumor microenvironment while avoiding potential toxicity associated with systemic administration of cytokines [[34], reviewed in [35]].